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Abstract
The protein kinase, PAK1, is overexpressed in human
breast cancer and may contribute to malignancy
through induction of proliferation and invasiveness.
In this study, we examined the role of PAK1 in the
survival of detached MCF10A breast epithelial cells to
test whether it may also regulate the early stages of
neoplasia. MCF10A cells undergo anoikis, as mea-
sured by the cleavage of caspase 3 and poly(ADP-
ribose) polymerase (PARP), after more than 8 hours of
detachment. Endogenous Akt, PAK1, and BAD are
phosphorylated in attached MCF10A cells, but these
phosphorylation events are all lost during the first
8 hours of detachment. Expression of constitutively
active PAK1 or Akt suppresses the cleavage of
caspase 3 and PARP in detached MCF10A cells. Co-
overexpression of active PAK1 with dominant-negative
Akt, or of active Akt with dominant-negative PAK1, still
suppresses anoikis. Thus, Akt and PAK1 enhance
survival through pathways that are at least partially
independent. PAK1-dependent regulation of anoikis is
likely to occur early in the apoptotic cascade as
expression of dominant-negative PAK1 increased the
cleavage of the upstream caspase 9, while constitu-
tively active PAK1 inhibited caspase 9 activation.
These results support a role for activated PAK1 in
the suppression of anoikis in MCF10A epithelial cells.
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Introduction
Epithelial cells undergo apoptosis when they lose contact
with the extracellular matrix (ECM), or bind to an inap-
propriate integrin [1]. This phenomenon has been called
anoikis, and it prevents shed epithelial cells from coloniz-
ing elsewhere and thus protects against neoplasia [2].
Anoikis is also an important mechanism in the initial cavi-
tation step of embryonic development [3] and in mammary
gland involution [4], and has been studied extensively
in angiogenesis research [5]. Failure of anoikis possibly
contributes to the malignancy of mammary glands and
other carcinomas [6–8].
The p21-activated kinase (PAK) family is homologous to the
yeast sterile 20 (Ste 20), and regulates a wide variety of
cellular responses, including cell morphology, proliferation,
and survival. PAKs were first identified in screens for binding
targets of Rac and Cdc42 [9]. Multiple pathways lead to
activation of PAK1 [10], some of which [e.g., Gbg subunits that
stimulate PAK1 through activation of phosphatidylinositol
3-kinase (PI3-kinase) and Akt] are independent of Rac1/
Cdc42 [11]. Activation of PAK1 by diverse signals leads to
autophosphorylation at several sites, including threonine-423
(T423) within the activation loop of the kinase. PAK1 phos-
phorylation at T423 has been linked to its activation, as
substitution of the acidic residue glutamic acid (E) at this site
yields a constitutively active T423E PAK1 enzyme [12].
PAKs are involved in the regulation of the apoptotic death
pathway. In Jurkat cells, for example, expression of dominant-
negative PAK1 inhibited fragmentation into apoptotic bodies,
and PAK function is also required for the stimulation of JNK
by Fas [13]. However, in HeLa and NIH3T3 cells, overexpres-
sion of wild-type or constitutively active PAK4 protects these
cells from apoptosis in response to serum withdrawal, UV ir-
radiation, and TNFa treatment. Expression of PAK4 inhibits
the activation of caspase 3–like enzymes, and specifically pro-
motes the phosphorylation of BAD on serine-112 (Ser-112)
[14]. PAK1 is activated by IL-3 (a cytokine) in FL5.12 lym-
phoid cells, and active PAK1 protects these cells from apop-
tosis by phosphorylating BAD [15]. Inhibition of PAK1 has
also been reported during detachment-induced death of NIH-
3T3 fibroblasts [16].
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PAK1 has been strongly implicated in breast cancer. It is
overexpressed in human breast cancer [17,18], probably, at
least in some cases, due to gene amplification [19]. PAK1 has
been shown to mediate cellular effects of polypeptide growth
factors on the motility and invasiveness of human breast
cancer cells, and to promote their anchorage-independent
growth [20,21]. In murine models, it was shown that inhibition
of PAK1 kinase activity by a dominant-negative fragment or
by short-interference RNA drastically reduced transactiva-
tion functions of estrogen receptor-a. Mammary glands from
mice expressing constitutively active T423E PAK1 (PAK-TE)
developed widespread hyperplasia during lactation [22].
Additional work performed by this group revealed that estro-
gen rapidly activated PAK1 in a PI3-kinase– independent
manner. Furthermore, estrogen induced the phosphorylation
and perinuclear localization of the cell survival forkhead
transcription factor, FKHR, in a PAK1-dependent process.
PAK1 directly interacts with FKHR and phosphorylates it [23].
A further connection from PAK1 to mammary hyperplasia
is that PAK1 activity stimulates cyclin D1 expression [17].
Detachment-induced apoptosis is suppressed in epithelial
cells transformed by ras and src oncogenes [1]. Active forms
of Ras protein are capable of protecting cells from anoikis by
stimulating PI3-kinase through direct interaction with the
catalytic p110 subunit, leading to the activation of Akt [24].
Ras transformation involves the synergistic effects of the Ras/
Raf/MAPK pathway and the PI3-kinase/Akt pathway [25]. In
studies of Ras transformation of Rat-1 fibroblasts, it has been
shown that PAK is necessary for the cooperative transforma-
tion of Rat-1 fibroblasts by Ras, Rac, and Rho [26–29]. Akt
may be a key intermediate between Ras and PAK1 in this
pathway. In human breast cancer, suppression of anoikis
by activated Ras has recently been reported to be indepen-
dent of both ERK MAP kinases and PI3-kinase/Akt [30].
In this study, we were interested in whether PAK1 plays a
role in cell survival in MCF10A human breast epithelial cells.
MCF10A cells are derived from MCF10M human epithelial
cells, which were obtained from a woman with fibrocystic
disease [31]. The first spontaneous immortalization of the
MCF10M cells resulted in MCF10A andMCF10F cells, which
are routinely used as normal immortalized breast epithelium
controls for studies of human breast cancer cells lines [32].
We are able to show that, within 24 hours of growth in
suspension, MCF10A cells begin undergoing apoptosis as
evidenced by cleavage of caspase 3 and poly(ADP-ribose)
polymerase (PARP). Overexpression of active PAK1 or
active Akt blocks cleavage of caspase 3 and PARP, revealing
a protective role for these kinases in the prevention of anoikis.
These results indicate that inappropriate activation of PAK1
could play a role in aberrant cell survival in human breast
epithelial cells.
Materials and Methods
Plasmids and Antibodies
Antibodies to the C-terminus of PAK1 (c19) and to cas-
pase 3 were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Antibodies to phosphoPAK1 (Thr-423)/
PAK2 (Thr-402), phosphoAkt (Ser-423), total Akt, total BAD,
phosphoBAD (Ser-112 and Ser-136), and phospho-p70
S6 kinase (Thr-421 and Ser-424) were purchased from Cell
Signalling Technology (Beverly, MA). The caspase 9 anti-
body was purchased from Stressgen (Victoria, BC, Canada).
PARP antibody was purchased from Biomol Research
Laboratories (Plymouth Meeting, PA). Anti –glyceralde-
hyde-3-phosphate dehydrogenase (GADPDH) monoclonal
antibody was purchased from Calbiochem (San Diego, CA).
Lipofectamine 2000 Plus was purchased from Invitrogen
(Carlsbad, CA). Plasmids used in this study include pRK7
and pRK7mycPAK1 [10]. Expression vectors pRK7myc-
PAK-299R and pRK7mycPAK-TE were prepared from
pCMV6mycPAK-299R and pCMV6mycPAK-TE, respec-
tively (kind gifts from Jonathan Chernoff), by subcloning
BamHI/EcoRI fragments into pRK7. Dominant-negative Akt,
pCMV6.HA.Akt-K/M, and active Akt, pCMV6.myr-Akt.HA,
plasmids were kind gifts from Alex Toker.
Cell Culture and Transfection Assays
Immortalized nonmalignant human breast epithelial
MCF10A cells were cultured as described previously [33].
Briefly, MCF10A cells were incubated in 100-mm dishes in
DMEM/F-12 medium supplemented with 5% horse serum,
0.5 mg/ml hydrocortisone, 10 mg/ml insulin, 20 ng/ml epider-
mal growth factor, 0.1 mg/ml cholera enterotoxin, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine.
MCF10A cells were transfected with Lipofectamine 2000
Plus reagent with 20 mg of pRK7myc-PAK1 plasmid, 20 mg
of pRK7mycPAK-299R, 20 mg of pRK7mycPAK-TE, 10 mg of
pCMVHA.Akt-K/M, 10 mg of pCMVHA.Akt, 10 mg of
pCMVHA.myr-Akt, or with 20 mg of pRK7 plasmid alone (as
a negative control). Control transfections using a pRK7
plasmid with an enhanced green fluorescent protein insert
demonstrated that approximately 20% of the cells was
strongly fluorescent and a similar additional proportion
exhibited much weaker fluorescence (data not shown).
Anoikis Assay
Cells were trypsinized 48 hours posttransfection, trans-
ferred to 15-ml conical tubes, washed, collected by centrifu-
gation for 5minutes at 500g, and counted. A total of 1.5 106
cells were transferred to either 100-mm culture dishes or
100-mm polyhema-coated Petri dishes, and cultured as
previously described [33]. At the indicated times, the sus-
pended cells were washed twice with phosphate-buffered
saline (PBS) and then lysed with 200 ml of boiling 2 Laemmli
buffer. The medium from the attached cells was reserved to
a 15-ml conical tube. The attached cells were harvested by
trypsinization, combined with the appropriate reserved me-
dium, and centrifuged. The cells were washed twice with PBS
and then lysed with 200 ml of boiling 2 Laemlli buffer.
Agonist Treatment and Detection of Active
Endogenous PAK1
MCF10A cells were grown to confluency on 100-mm
culture dishes and treated as previously described [10,11].
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Immunoblot Analysis
Cells lysates in 2 Laemlli buffer were boiled for 10 min-
utes and then subjected to SDS-PAGE. After electro-
phoresis, the proteins were transferred to nitrocellulose
membranes. Western blot analysis with enhanced chemi-
luminescent detection was performed as previously de-
scribed [10]. All results shown are representative of at least
three independent experiments.
Results
Time Course of PARP Cleavage in MCF10A Cells Grown
in Suspension
To establish a system in which the induction of anoikis in
MCF10A cells could be assayed, we measured the cleavage
of PARP with time following suspension. PARP is a substrate
of caspase 3 and its cleavage occurs in the late stage of
apoptosis. PARP cleavage in MCF10A cells has been
reported in cells grown for 24 hours in suspension [33]. We
therefore tested cells that were grown in suspension or
attached in enriched media from 0 to 48 hours. In the cells
that were attached, there was minimal PARP cleavage
detected. However, in cells grown in suspension for 8 to
48 hours, there was detectable PARP cleavage (Figure 1).
To confirm the fraction of cells that undergo anoikis follow-
ing suspension, we monitored general cellular morphology
by phase microscopy and nuclear morphology by 4,6-
diamidino-2-phenylindole (DAPI) fluorescent microscopy.
Within 48 hours of suspension, the majority of the cells
exhibited a shrunken and blebbed morphology with con-
densed and fragmented nuclei (data not shown).
Endogenous PAK1, Akt, and BAD Phosphorylation
Decreases in MCF10A Cells Grown in Suspension
Our hypothesis is that anoikis is regulated by the activity
of critical serine–threonine kinases such as PAK1 and Akt.
We therefore determined whether the activation/phosphory-
lation status of endogenous PAK1 and Akt differed in sus-
pended versus attached MCF10A breast epithelial cells
during the time period when anoikis is induced. The pro-
apoptotic factor, BAD, is known to be phosphorylated by
PAK1 and Akt [15]; thus, we also assayed BAD phosphory-
lation levels under the same conditions. PAK1, Akt, and BAD
were all phosphorylated in MCF10A cells that were attached
and grown in media-containing serum (Figure 2). After
2 hours in suspension, no PAK1 Thr-423 or BAD Ser-112
phosphorylation was detected, and Akt phosphorylation at
Ser-423 and BAD phosphorylation at Ser-136 was reduced.
After 8 hours in suspension, neither Akt Ser-423 nor BAD
Ser-136 phosphorylation was detected (Figure 2). These
results are therefore consistent with a system in which the
unphosphorylated forms of PAK1, Akt, and BAD may con-
tribute to the induction of anoikis in MCF10A cells.
Endogenous PAK1 Is Activated in MCF10A Cells Treated
with EGF or LPA
We have previously shown that PAK1 can be activated by
several agonists, such as LPA and EGF, in NIH3T3 cells
[10]. Because growth factor regulation of PAK1 activity may
be important in breast epithelial cells, we determined if
endogenous PAK1 would be activated following treatment
of MCF10A cells with LPA or EGF. PAK1 activation, as
assayed by its phosphorylation at Thr-423, was increased
in MCF10A cells treated with LPA or EGF (Figure 3).
Inhibition of PARP Cleavage Occurs in Cells
Overexpressing Active PAK1 or Active Akt
Our hypothesis is that PAK1 plays a key role in cell
survival mechanisms in MCF10A breast epithelial cells,
and that its action should therefore be compared to that of
Akt, which is known to be important in mammary carcinoma
[34]. To test whether PAK1 could be involved in rescuing
cells from anoikis, we overexpressed dominant-negative
PAK-299R, active PAK-TE, wild-type PAK1, wild-type Akt,
dominant-negative Akt-K/M, or active myr-Akt in MCF10A
cells. After allowing the cells to grow for 48 hours posttrans-
fection, cells were split and plated on culture dishes or
polyhema-coated Petri dishes for 24 hours. In negative
control, vector-transfected cells, and cells overexpressing
dominant-negative PAK-299R or dominant-negative Akt-K/M,
the suspended cells exhibited PARP cleavage (Figure 4).
Expression of dominant-negative PAK1 or Akt did not induce
PARP cleavage in cells that retained attachment. In cells
overexpressing active forms of PAK1 or Akt, this cleavage
was inhibited (Figure 4). To a lesser extent, overexpression
of wild-type PAK1 or Akt also reduced PARP cleavage. The
coexpression of dominant-negative PAK1 with active myr-
Akt did not reverse the protective role of active Akt, nor did
the coexpression of dominant-negative Akt-K/M with active
Figure 1. Time course of PARP cleavage in MCF10A cells grown in suspension. Cells were grown either attached on regular culture dishes or in suspension on
polyhema-coated Petri dishes for times ranging from 0 to 48 hours. PARP cleavage was detected by Western blot analysis of cell lysates for the appearance of the
85-kDa fragment.
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PAK-TE reverse the protective role of PAK1 in these cells
(Figure 4). These results suggest that active PAK1 and active
Akt protect MCF10A cells from undergoing anoikis.
To confirm that the dominant-negative Akt construct was
inhibiting Akt activity when transfected into MCF10A cells,
despite its failure to induce PARP cleavage in the attached
cells and its lack of effect to block protection by active PAK1,
we assayed the phosphorylation of p70 S6 kinase as a marker
of cellular PI3-kinase activity [35]. Phosphorylation of p70S6K
was inhibited by transfection with dominant-negative Akt,
but not by dominant-negative PAK1 (Figure 4D).
Caspase 3 Cleavage Is Inhibited by Overexpression of
Active PAK1 and Active Akt
To further investigate the role of PAK1 in cell survival,
we assayed the cleavage of caspase 3 inMCF10A cells grown
in suspension. Caspase 3 cleavage was detected in control
transfections of cells and in cells overexpressing dominant-
negative PAK1 or dominant-negative Akt (Figure 5). Expres-
sion of dominant-negative PAK1 or Akt did not induce
caspase 3 cleavage in cells that retained attachment. The
cleavage of caspase 3 in cells grown in suspension could
be inhibited when active PAK1 or Akt was overexpressed
(Figure 5). Interestingly, coexpression of active PAK1 with
dominant-negative Akt still inhibited caspase 3 cleavage, as
did coexpression of active Akt with dominant-negative PAK1
(Figure 5). These results indicate a role for both PAK1 and Akt
in cell survival through the suppression of anoikis. Further-
more, these results suggest that this protection could take
place by two pathways that are at least partially independent.
Caspase 9 Cleavage Is Inhibited in MCF10A Cells
Overexpressing Active PAK1
To further define the effect of PAK1 on inhibiting the
apoptotic cascade, we assayed the cleavage of caspase 9.
Caspase 9 is a more upstream element that is capable of
cleaving caspase 3 [36,37]. In MCF10A cells grown in sus-
pension, there is cleavage of caspase 9 (Figure 6). Expres-
sion of active PAK1 inhibited caspase 9 cleavage, whereas
expression of dominant-negativePAK1 in suspendedMCF10A
cells increased caspase 9 cleavage (Figure 6). Once again,
dominant-negative PAK1 did not induce cleavage of cas-
pase 9 in cells that retained attachment. These results indi-
cate that PAK1 activation can regulate caspase 9 activation
in detached MCF10A cells.
Discussion
A balance between cell proliferation, cell differentiation, and
cell death in the stem cell population and throughout the
mammary gland is critical for normal development. In con-
trast, perturbations in this balance can contribute to carcino-
genesis. Conditions that upregulate cell proliferation or
downregulate apoptosis can lead to accumulation of muta-
tions, which contribute to the subsequent development of
breast cancer. Atypical ductal hyperplasia is an abnormal
ductal epithelial proliferative stage that can become more
aggressive and eventually fill the lumen of the duct; thus, it is
considered a precursor of development of ductal carcinoma
in situ [38–41]. Presumably a failure of anoikis is required
for the early stages of mammary epithelial transformation.
The breakdown of anoikis is expected to confer a selective
Figure 2. Decrease in endogenous PAK1, Akt, and BAD phosphorylation in
MCF10A cells grown in suspension. MCF10A cells were grown either
attached (t = 0) or suspended for 2, 4, or 8 hours. (A) Western blots of whole
cell lysates were probed with anti –phospho Akt (Ser-423) to detect active
Akt, and then stripped and reprobed with anti-Akt to detect total Akt. (B)
Western blots of whole cells lysates were probed with anti –phospho PAK1
(Thr-423) to detect active PAK1 (the doublet observed may be due to the fact
that the antibody will also react with any endogenous PAK2 that may be
present and phosphorylated on residue Thr-402), and then stripped and
reprobed with anti –Pak c-19 to detect total PAK1. (C) Western blots of whole
cell lysates were probed with anti –phospho-BAD (Ser-136) to detect
phosphorylated BAD, then stripped and reprobed with anti –phospho-BAD
(Ser-112) to detect phosphorylated BAD, and then stripped and reprobed with
anti-BAD to detect total BAD.
Figure 3. Endogenous PAK1 is activated by EGF and LPA in MCF10A cells.
MCF10A cells were treated with 100 nM EGF or 10 M LPA for 5 minutes and
lysates were prepared. The results shown are for two independent isolates of
each condition that were analyzed on the same gel. After detection of active
phosphorylated PAK1 (top panel), the blots were stripped and reprobed for
total PAK1 (bottom panel).
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advantage on precancerous epithelial cells, affording them
an increased survival time in the absence of matrix attach-
ment, and facilitating eventual reattachment and colonization
of secondary sites.
Detachment of endothelial and epithelial cells from the
ECM induces the cells to undergo a form of apoptosis known
as anoikis [1,42]. Many of the signals from the ECM, includ-
ing those for cell survival, are relayed to the intracellular
signaling machinery by integrins—heterotrimeric transmem-
brane receptors with overlapping specificity toward ECM
components [42–44]. Matrix binding to cell surface integrins
can trigger survival signaling for cells through the activation
of PI3-kinase and FAK [24,45]. Akt, a downstream effector of
PI3-kinase, is responsible for transmitting the matrix-induced
survival signal [46]. It has also been reported that FAK, in
conjunction with fibronectin, is capable of suppressing an
apoptotic pathway regulated by the tumor-suppressor p53 in
fibroblasts and endothelial cells [47,48].
We have shown that active PAK1 and active Akt are
involved in cell survival as they prevent caspase activation
Figure 4. Cleavage of PARP is inhibited by overexpression of active PAK1 or active Akt. MCF10A cells were transfected with plasmids encoding wild-type (wt),
active (PAK-TE or myr-Akt), or dominant-negative (PAK-299R or Akt-K/M) forms of PAK1 and Akt as shown. Cells were grown for 48 hours posttransfection,
counted, and split into two plates: one regular culture dish and one polyhema-coated Petri dish for a further 24 hours. Cell lysates were then processed for PARP
cleavage (A), the presence of the myc tag on the transfected PAK1 constructs (B), and the presence of the HA tag on the transfected Akt constructs (C). Lysates
from attached cells were also immunoblotted for phospho-p70S6K as a downstream marker of cellular Akt activity, followed by anti-GAPDH as a loading control (D).
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and PARP cleavage in MCF10A cells grown in suspension.
The protective effect is most pronounced for constitutively
activated forms of Akt and PAK1, but overexpression of wild-
type Akt and PAK1 also reduced the cleavage of PARP and
caspase 3. It may well be relevant to consider the potential
role of growth factors in the stimulation of Akt and PAK1 and
whether this may also contribute to the suppression of
apoptosis by growth factors. Inadequate growth factor sig-
naling, for example, leads to apoptosis, and several lines of
evidence suggest that this death may be due to loss of mito-
chondrial homeostasis [49]. Our results show that PAK1
can be activated in MCF10A cells by both EGF and LPA.
Several antiapoptotic pathways have been defined for Akt.
For example, it is known that Akt translocates to the nucleus
and is capable of phosphorylating transcription factors such as
CREB, forkhead, E2F, and NFnB [50]. Akt can also phosphor-
ylate and thereby inactivate the proapoptotic Bcl-2 member
BAD,which leads to protection fromapoptosis. Caspase 9 and
forkhead are capable of inducing apoptosis, which can be
inhibited by Akt-mediated phosphorylation of both proteins. In
addition, Akt is linked to the activation of NFnB, which pro-
motes expression of antiapoptotic genes. Notably, Akt is also
required for the activation of PAK1 by Ras [29]. This result
implies that PAK1 or some PAK activator may be a critical Akt
substrate. It has been shown that Akt phosphorylates PAK1
at Ser-21 and that expression of Akt can release PAK1 from
Nck [51]. In our study, expression of the dominant-negative
PAK-299R in cells overexpressing active Akt did not reverse
the inhibition of caspase 3 or PARP cleavage inMCF10A cells
(Figures 4 and 5). It is possible that, in addition to PAK1, Akt
mediates cells survival through a different downstream effec-
tor. It is notable, therefore, that Akt, PAK1, and PAK4 are all
capable of phosphorylating BAD [14,15,52], and that the
inhibition of anoikis that was conferred by active PAK1 was
also not blocked by dominant-negative Akt. Therefore, one
conclusion from our studies is that active PAK1 and Akt can
both suppress anoikis in MCF10A cells and that they act to
suppress apoptosis through mechanisms that are at least
partially independent. It is important to note, therefore, that
suppression of anoikis in human breast cancers induced by
Ras activation has recently been shown to be independent of
both Akt and ERK [30]. Our data also show that expression of
dominant-negative PAK1 or Akt is insufficient to trigger apop-
tosis in MCF10A cells if they remain attached.
Figure 5. Cleavage of caspase 3 is inhibited by overexpression of active PAK1 and active Akt. MCF10A cells were transfected with plasmids encoding wild-type
(wt), active (PAK-TE or myr-Akt), or dominant-negative (PAK-299R or Akt-K/M) forms of PAK1 and Akt as shown. Cells were grown for 48 hours posttransfection,
counted, and split into two plates: one regular culture dish and one polyhema-coated Petri dish for a further 24 hours. Cell lysates were then processed for detection
of caspase 3 cleavage, which is revealed by the appearance of an 18-kDa fragment (upper panel). Blots were also probed with 9e10 to detect myc-tagged PAK1
constructs (middle panel) and with 12Ca5 to detect HA-Akt constructs (lower panel).
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The readily apparent differences between the cytoskele-
tal structures of attached versus suspended cells suggest
that survival signaling in anoikis is likely to be extensively
regulated by the cytoskeleton. Such regulation may be
affected by the multiple cytoskeletal changes in transformed
cells [53]. PAK1 is a downstream effector of Rac and Cdc42,
which are both known to be involved in cytoskeletal rear-
rangements [54–56]. Active PAK1 itself is believed to alter
the cytoskeleton, and localization of PAK1 to the plasma
membrane has been shown to induce neurite outgrowth in
PC12 cells [57–59]. PAK1 may therefore play a central role
in cell survival signaling pathways through modulation of the
cytoskeleton. We have shown that active PAK1 expression
in MCF10A cells inhibits suspension-induced anoikis. PAK1
may very well be complexed at focal adhesions with other
proteins. A fibronectin-dependent matrix survival pathway
has been proposed, in which fibronectin supports a prosur-
vival signaling complex based on focal adhesion kinase and
the adaptor protein p130 Cas located at focal adhesions [60].
Paxillin is thought to participate in the binding of focal ad-
hesion kinase to focal adhesion sites [61]. The fibronectin/
focal adhesion kinase–associated survival signals activate
Ras and are propagated further through Rac/PAK1/MKK4/
JNK signaling, with phosphorylated JNK detected at the
focal adhesion as well as in the nucleus. This pathway is
independent of the serum-dependent pathway that is acti-
vated when matrix is withdrawn. This serum-dependent
pathway requires FAK and PI3-kinase [60]. In the future,
determination of the downstream targets of PAK1 in survival
would give insights as to the exact role PAK1 plays in cell
survival and anoikis.
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